Turkey

'Turkey sees 2nd COVID-19 peak in Anatolian region'

Country faces risky increase in number of coronavirus patients, warns Heath Minister Fahrettin Koca

Erdogan Cagatay Zontur and Seda Sevencan   | 23.10.2020
'Turkey sees 2nd COVID-19 peak in Anatolian region'

ANKARA

Turkey is seeing a second COVID-19 peak in the Anatolian heartland region, with a dangerous rise in the number of patients, the country's Health Ministry said Friday.

"The pandemic is in its second peak in Anatolia. We are facing a risky increase," Fahrettin Koca told a news conference following a meeting with local officials.

Koca also offered good news, saying that Turkey expects to have some 5 million doses of a COVID-19 vaccine – possibly one from China or from the drug company Pfizer – with few side effects ready by December.

“In line with our expectations, in December if immunity levels are well developed, we think this vaccine will be applied in Turkey,” he said.

But Koca again urged continued measures to stem the virus’ spread.

“We must minimize the time we spend outside. Let's stay at home except for our occupations and obligations,” he said.

If people neglect protective measures, “winter will be a period of defeat for all of us with the effect of indoor environments,” he added.

Looking ahead to flu season, Koca said Turkey is currently acquiring two times more influenza vaccine than it did last year, adding: "We are working to increase the number to 3 million or even more."

Separately, the National Education Ministry announced that as of Monday, special education students will start week-round, in-person education.

Nearly 41.86 million people have tested positive for the novel pandemic globally, while nearly 1.14 million have died, and around 28.41 million have recovered, according to Johns Hopkins University’s running tally.

The US, India, and Brazil are currently the worst-hit countries.

Anadolu Agency website contains only a portion of the news stories offered to subscribers in the AA News Broadcasting System (HAS), and in summarized form. Please contact us for subscription options.
Related topics
Bu haberi paylaşın